Nutanix CFO Sells Over $668K in Stock; Acquires RSUs by Mark Eisenberg 20.06.2024 Nutanix CFO Duston Williams sells $668,787 in stock; insights into his trading activities and company’s robust financials, growth, and market ...
Navigating Retirement Investments Amid Inflation Risks by Mark Eisenberg 19.06.2024 Discover strategies for smart investing in retirement amidst inflation, ensuring financial security with diversified, adaptive approaches and expert guidance.
Enphase EVP Sells $616K in Stock Amid High Valuation by Mark Eisenberg 18.06.2024 Enphase Energy EVP sells $600k in stock; Insider transactions may signal personal planning or insights into company’s future. Analyst updates ...
Voip-Pal Director Dennis Chang Sells Over $11K in Shares by Lilu Anderson 18.06.2024 "Voip-Pal Director Dennis Chang sells $11K+ in shares. Key trading activities & financial metrics provide crucial insights for investors."
Sacks Parente Golf Director Purchases 30,833 Shares by Mark Eisenberg 18.06.2024 Sacks Parente Golf sees confidence boost as Director Brett Widney invests $15K, highlighting growth potential despite past stock volatility.
Piper Sandler Reaffirms Ellington With $13 Target by Mark Eisenberg 18.06.2024 "Piper Sandler reaffirms Ellington Financial as 'Overweight' with a $13 price target, citing strategic acquisitions and robust earnings outlook."
Aerovate Therapeutics Stock Downgraded After Trial Setback by Mark Eisenberg 17.06.2024 Aerovate Therapeutics stock downgraded by BTIG after AV-101 trial setback; mixed analyst views and future pivotal readouts crucial for investors.
Needham Boosts Zeta Global Shares Amid Strong Growth Factors by Mark Eisenberg 17.06.2024 Zeta Global sees robust growth with a 23.1% revenue increase, earning "Buy" ratings from major analysts despite a lack of ...
Schwab Exec Sells $600K+ in Stock, Exercises Options by Mark Eisenberg 15.06.2024 Charles Schwab Corp. faces near-term challenges like 2% cash outflows in May; Goldman Sachs maintains Neutral rating with a $75.00 ...
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive News by Terry Bingman 15.06.2024 Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.